市場調查報告書
商品編碼
1439488
子宮腔鏡設備 - 全球市場回顧、競爭格局、市場預測(2030)Hysteroscopes/Hysteroscopy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球子宮腔鏡設備市場規模將達到12.9億美元,到2030年將達到21.3億美元,預計2024-2030年期間複合年增長率為7.40%。 子宮腔鏡設備的需求增加主要是由於全球婦科疾病病例數量的增加和老年女性人口的增加。 此外,對微創手術偏好的改變、產品領域的技術進步、產品核准的增加等是預期推動市場成長的主要因素。
子宮鏡設備市場動態
由於世界各地女性婦科疾病的增加,子宮腔鏡設備市場目前正在蓬勃發展。 根據世界衛生組織 (WHO) (2022) 的數據,子宮內膜異位症是一種類似子宮內膜的組織生長在子宮外的疾病,影響全球約 10% 的育齡婦女和女孩。
此外,根據GLOBOCAN(2020)的統計,2020年全球新報告女性癌症病例數為9,227,484例,其中604,127例,即6.5%,被診斷為子宮頸癌。
此外,隨著年齡的增長,女性負擔日益加重,也是推動子宮鏡設備市場在未來幾年快速成長的因素之一。 這是因為,老年女性更容易罹患生殖器脫垂、停經後出血等各種婦科疾病。 例如,根據《2020年世界人口老化要點》,全球65歲以上人口約為7.27億,女性約佔全球65歲及以上人口的55%。
此外,各種先進子宮鏡設備的產品核准增加預計也將在預測期內快速成長子宮腔鏡設備市場。 例如,2020 年 7 月,Karl Storz SE & Co.KG 的 Endomat Select 獲得 FDA 批准,這是一種子宮腔鏡供氣裝置,可將無菌沖洗液注入輸尿管和上泌尿道。
此外,2020 年 1 月,LiNA Medical ApS 的子宮腔鏡 "LiNA OperaScope" 獲得 FDA 批准,用於在婦科診斷和治療過程中可視化子宮頸和子宮腔。
因此,所有上述因素預計將推動全球子宮腔鏡設備市場在預測期內快速成長。然而,子宮鏡的感染風險以及子宮腔鏡設備嚴格的監管審批流程可能會成為子宮腔鏡設備市場的限制因素。
此外,子宮鏡設備市場在 COVID-19 大流行期間經歷了緩慢增長。 這是因為大流行造成了全球衛生緊急情況,迫使人們保持社交距離並暫停非必要的訪問,以節省醫院資源來控制疫情。 此外,疫情期間暫停選擇性外科手術以及世界各國政府為遏制感染傳播而實施嚴格的指導方針也減緩了子宮鏡設備市場的發展。 然而,各種疫苗的推出和大規模疫苗接種運動有望幫助子宮鏡市場在疫情後恢復正常。
子宮鏡設備細分市場分析
在子宮鏡設備產品領域,子宮腔鏡細分市場(包括剛性子宮鏡和柔性子宮鏡類別)預計將在未來幾年佔據重要的市場份額。 由於柔性子宮鏡具有各種優點,因此比剛性子宮鏡更受青睞。 例如,在多項研究中,較小直徑的柔性子宮鏡已顯示出優於標準剛性子宮鏡的一些優勢。 它的侵入性較小,因為它不需要擴張子宮頸或肌腱。 因此,這些特徵與較少的痛苦有關。
此外,現代柔性宮腔鏡設備已顯著改進。 新的光纖、視訊系統、攝影機和照明提高了系統的品質。
本報告研究和分析了全球子宮腔鏡設備市場,提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes And Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy And Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), by geography, is anticipated to expand at a noteworthy CAGR forecast till 2030 due to the growing prevalence of gynaecological disorders and rising adoption rate of minimally invasive surgeries.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030. The increase in demand for hysteroscopy devices is predominantly attributed to the rising geriatric women population across the globe coupled with growing cases of gynecological disorders. In addition, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are some of the key factors which is expected to drive the growth of the global hysteroscopy devices market.
Hysteroscopy Devices Market Dynamics:
The market for hysteroscopy devices is gaining momentum at present owing to the rise in gynecological disorders among women across the globe. As per the World Health Organization (WHO) 2022 data, Endometriosis, a disease where tissue similar to the lining of the uterus grows outside the uterus affects roughly 10% (190 million) of reproductive age women and girls globally.
Moreover, according to the GLOBOCAN 2020 statistics, a total of 9,227,484 new cancer cases were reported among females, worldwide in the year 2020, out of which 6.5% or 604,127 were suffering from cervix uteri cancer.
In addition, the escalating burden of the women population tending towards old age is also another factor that could surge the market for hysteroscopy devices in the upcoming years. This is because old women are more susceptible to developing various gynecological disorders such as genital prolapse, postmenopausal bleeding, and others. For instance, according to the World Population Ageing 2020 highlights, there were approximately 727 million population aged 65 years or over, worldwide and women accounted for about 55% of the global population aged 65 years or over.
Furthermore, rising product approval of various advanced hysteroscopy devices is also anticipated to spike the market for hysteroscopy devices during the forecasted period. For instance, in July 2020, Karl Storz SE & Co. KG received FDA clearance for its Endomat Select, a hysteroscopy insufflator to provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, and others.
Also, in January 2020, LiNA Medical ApS received FDA approval for LiNA OperaScope, a hysteroscope intended for use in the visualization of the cervical canal and uterine cavity during diagnostic and therapeutic gynecological procedures.
Thus, all the above-mentioned factors are expected to surge the global market for hysteroscopy devices during the forecasted period.
However, the risk of infection from hysteroscopes and stringent regulatory approval process for hysteroscopy devices is likely to impede the hysteroscopy devices market.
Further, the market for hysteroscopy devices witnessed slow growth during the COVID-19 pandemic. This is because the pandemic has caused a global health emergency, enforcing social distancing and preserving hospital resources for the management of the outbreak thus suspending nonessential medical visits. In addition, halt in elective surgical procedures during the pandemic, implementation of stringent guidelines by the national governments across the globe to curb the transmission of the infection also slowed down the hysteroscopy devices market. However, the launch of various vaccines and mass vaccination drives will help in regaining normalcy to the hysteroscopy market during the post-pandemic period.
Hysteroscopy Devices Market Segment Analysis:
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments and Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Hysteroscopy Devices product segment, the hysteroscopes segment which is further subcategorized into rigid and flexible hysteroscopes is expected to hold a significant market share in the forthcoming years. The flexible hysteroscope is preferred over rigid hysteroscope due to various advantages associated with it. For instance, flexible hysteroscopes with smaller diameters have shown some advantages over standard rigid hysteroscopes in some studies. They are less invasive because there is no requirement for the dilation of the cervix or tendons. Thus, these features are associated with less pain.
Moreover, the latest flexible hysteroscopy equipment has been significantly improved. New fiber optics, video systems, cameras, and lighting have improved the quality of the systems.
For instance, in March 2019, Hologic received a CE mark for its Omni hysteroscope, a three-in-one modular scope with visualization capabilities designed for both diagnostic and therapeutic hysteroscopy procedures. The reusable rod lens of the hysteroscope utilizes rod lenses for visualization and fibers for illumination.
Hence, all the aforementioned factors are projected to contribute to the segmental growth of the global hysteroscopy devices market in the upcoming years.
North America is expected to dominate the Overall Hysteroscopy Devices Market:
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forthcoming years. This domination is owing to the increasing concern of gynecological and reproductive health problems among the women in the region. In addition, the rise in hysteroscopy procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the rise in awareness about women's health, among others are also expected to bolster the market for hysteroscopy devices.
For instance, in the US, according to the American Cancer Society 2022 statistics, approximately 66,750 new cases of uterine/endometrial cancer are expected to be diagnosed in the same year.
In addition, as per the Office of the Assistant Secretary for Health (OASH) 2019 data, more than 11% of American women between 15 and 44 age were suffering from endometriosis in the same year.
Furthermore, an increase in hysteroscopy procedures in the country will also contribute to the market growth of hysteroscopy devices. For instance, as per the data revealed by the Center for Menstrual Disorders 2022, in the year 2017, there were over 500,000 hysteroscopic endometrial ablations performed in the United States per year. The center has performed nearly 3500 major operative hysteroscopy procedures till January 2018.
Moreover, the presence of key manufacturers in the region such as Medtronic, Hologic, CooperSurgical, and Stryker, among others, and various product approvals belonging to hysteroscopy procedures are anticipated to spike the market for hysteroscopy devices in the region. For instance, recently on September 25, 2020, Stryker received FDA clearance for various versions of Reprocessed MyoSure Tissue Removal Devices to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.
Thus, all the above-stated factors are expected to propel the hysteroscopy devices market in the region.
Further, the Asia-pacific region has future potential for the hysteroscopy devices market. The increasing old-age female population is the key driving factor. For instance, according to the United Nations Population Fund 2022 statistics, the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 where women constitute the majority (53%) of the population aged 60 or older in the region. It is also estimated that their share will rise to 60% for ages above 80 years. Additionally, the rising burden of gynecological disorders, presence of regional as well as global leaders active in manufacturing hysteroscopy devices such as Olympus and Advin Health Care, among others in the region is likely to contribute to the market growth during the forecasted period.
Hysteroscopy Devices Market Key Players:
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Recent Developmental Activities in the Hysteroscopy Devices Market:
In October 2022, Hologic launched its expanded gynecological surgical offering, Omni suite, in Europe, Africa, and the Middle East (EMEA). The expanded offering currently includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal.
In January 2022, Hologic launched Fluent® Fluid Management System for hysteroscopic procedures in Europe.
In May 2020, Olympus signed an exclusive agreement with UVision360, Inc. to distribute the LUMINELLE® DTx Hysteroscopy System in the U.S.
Key Takeaways from the Hysteroscopy Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Hysteroscopy Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Hysteroscopy Devices Market.
Various opportunities available for the other competitor in the Hysteroscopy Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Hysteroscopy Devices market growth in the coming future?
Target Audience who can be benefited from the Hysteroscopy Devices Market Report Study
Hysteroscopy Devices providers
Research organizations and consulting companies
Hysteroscopy Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Hysteroscopy Devices
Various End-users who want to know more about the Hysteroscopy Devices Market and latest technological developments in the Hysteroscopy Devices market.
Frequently Asked Questions for the Hysteroscopy Devices Market:
Hysteroscopy is a procedure that allows a healthcare professional to look inside the uterus to diagnose and treat the causes of various gynecological disorders. The medical devices used during the procedure are in general known as hysteroscopy devices and mainly include hysteroscopes, hysteroscopy fluid management systems, hysteroscopy dilators, and others.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030.
The major factors driving the demand for Hysteroscopy Devices are the growing geriatric women population across the globe coupled with growing cases of gynecological disorders. Furthermore, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are also expected to drive the growth of the global hysteroscopic devices market.
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forecasted period, 2024-2030. This domination is owing to the rapidly increasing concern of gynecological and reproductive health problems among the female in the region. Also, the rise in hysteroscopic procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the growing awareness about women's health, among others are expected to bolster the market for hysteroscopic devices.